Once the clot lodges in the blood vessels of the lungs, it can cause lung damage or block circulation, which can lead to death
305, R68R77
MedBound Hub GLP-1 Drugs: Fighting Diabetes and Weight Gain General Madhumathi.N.Lambi December 25, 2025, 1:49pm 1 GLP-1 Drugs: Fighting Diabetes and Weight In recent years, GLP-1 receptor agonists have transformed the treatment landscape for type 2 diabetes and obesity, blurring the line between metabolic disease management and weight-loss therapy
The STEP trials, which enrolled over 4,500 participants taking semaglutide, documented appendicitis incidents at rates comparable to or lower than the general population baseline
Since the introduction of exenatide in 2005, a growing number of these drugs has transformed the management of type 2 diabetes (T2D)
Metabolic labs may be checked when clinically appropriate, and A1C or glucose monitoring is more relevant for diabetes or prediabetes